Dhanuka Agritech Limited (DHANUKA) has reported a significant improvement in its second-quarter profitability for FY27, with its Profit After Tax (PAT) growing 16.23% year-on-year to ₹109.22 crore. Revenue from operations for the quarter increased 9.91% to ₹657.51 crore, against ₹598.25 crore in Q2 FY26. This profit growth outpaces revenue growth as the agrochemical major reports improved profitability in Q2 FY27.

Financial Highlights

The financial performance of Dhanuka Agritech in Q2 FY27 was marked by several key metrics:

Revenue from Operations: ₹657.51 crore (Up 9.91%)

Gross Profit: ₹270.77 crore (Up 6.62%)

Gross Profit Margin: 41.18% (compared to 42.45% in Q2 FY26)

EBITDA: ₹152.97 crore (Up 11.88%)

Profit Before Tax (PBT): ₹146.47 crore (Up 16.27%)

Profit After Tax (PAT): ₹109.22 crore (Up 16.23%)

Management Commentary

Commenting on the performance, Mr. Rahul Dhanuka, Managing Director, Dhanuka Agritech Limited said: “Our Q2 profitability expansion was supported by healthy channel inventory liquidation and steady demand during the autumn farming cycle. We remain focused on building a sustainable and innovation-led growth platform for Dhanuka Agritech. The Indian agricultural sector continues to present significant opportunities, particularly in the areas of crop productivity, advanced crop protection solutions and the adoption of innovative agricultural technologies. Our focus remains on strengthening our product portfolio, deepening farmer engagement, and expanding our market presence. We believe that continued investment in innovation and farmer-centric solutions will remain central to our long-term growth journey.”

The unaudited financial results for the quarter and half year ended September 30, 2026, were reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on October 30, 2026.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Dhanuka Agritech Limited

Dhanuka Agritech Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.

Dhanuka falls 14.6% over three months and has not found a floor yet. The PEG of 2.06 makes it expensive versus peers. The premium needs earnings to catch up quickly. No meaningful dividend — total return is entirely dependent on capital appreciation. RSI stands at 31, well into oversold territory. Yet sellers still dominated on 15 of recent sessions versus 15 for buyers, so the pressure has not fully lifted. Revenue grows at 5.1% CAGR — a respectable pace. However, the stock drops 14.6% in three months without an obvious fundamental trigger. Sector-wide pressure or a valuation re-rating can persist for longer than expected. Therefore, there is no rush to step in. Check Fundamentals of Dhanuka Agritech Limited.

Sharda Cropchem Limited (SHARDACROP) has unveiled its investor presentation for October 2026, highlighting a steady, strong, and growing trajectory for the company. The presentation underscores the company’s commitment to advancing global agriculture through an IP-led growth platform.

Advancing Global Agriculture

SHARDACROP is a leading intellectual property-driven agrochemical company engaged in the marketing and distribution of crop protection formulations and generic active ingredients. The company’s strategy focuses on leveraging a growing portfolio of dossiers, registrations, and intellectual property rights to build a differentiated platform for sustainable growth across regulated global markets.

Asset-Light, Registration-Led Business Model

The company’s core capabilities include basic and applied research, product identification, product registration, active ingredient manufacturing, formulation, and marketing distribution. By partnering with specialized manufacturers for manufacturing-related activities, SHARDACROP remains capital efficient, operationally agile, and well positioned to scale across geographies and product categories.

Global Market Reach

Supported by a network of over 525 distributors and 500 sales professionals, SHARDACROP serves customers across more than 80 countries. This extensive global presence not only expands the company’s market reach but also enables access to specialized sales and local marketing talent across key agricultural regions.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Sharda Cropchem Limited

Sharda Cropchem Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.

Sharda drops 19.3% over three months and trades near its 52-week lows. The PEG of 0.41 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Revenue and profit grow at 9.2% and 25.8% CAGR respectively. The pace is steady, and stability drives the investment case. The stock sits at 5% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. The business compounds at 9.2% revenue and 25.8% profit CAGR, with D/E of 0.00. Yet the stock drops 19.3% in three months. The business does not deteriorate — the stock does. That gap is what long-term investors look for. Check Fundamentals of Sharda Cropchem Limited.

PI Industries Limited (PIIND) has made a groundbreaking announcement today, unveiling Pioxaniliprole, India’s first indigenously discovered insecticide. This decade-long research breakthrough marks a defining milestone in India’s ability to originate world-class agricultural science and proprietary innovation.

A Milestone in Agricultural Innovation

Developed through more than a decade of original research, Pioxaniliprole demonstrates the country’s growing capability to originate novel scientific discoveries and create proprietary intellectual property. This achievement strengthens PI’s ambition to build a global, innovation-led Life Sciences company, creating original science and intellectual property from India for the world.

Significance Beyond a Single Molecule

The significance of Pioxaniliprole extends beyond a single molecule. It is the first outcome of a broader innovation pipeline at PI, spanning chemistry, biology, and biochemical solutions. Together, these mark an important step in India’s journey towards greater scientific self-reliance, strengthening indigenous research capabilities and creating opportunities for Indian-origin agricultural innovation to address challenges of global relevance.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of PI Industries Limited

PI Industries Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.

PI drops 16.5% over three months and trades near its 52-week lows. The PEG stands at 11.88 — severely stretched. Any earnings miss could trigger a sharp de-rating. Revenue grows at 1.1% CAGR. The company generates cash but does not compound aggressively. The stock sits at 5% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 1.1% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of PI Industries Limited.